Dabur takes Patanjali Ayurved to court over 'disparaging' Chyawanprash ad

Initially, the court asked the company to refer the case to mediation but later it decided to hear the matter after Dabur pressed for immediate relief

By  Storyboard18Dec 24, 2024 7:20 PM
Dabur takes Patanjali Ayurved to court over 'disparaging' Chyawanprash ad
Patanjali's Chyawanprash ad under scrutiny as Dabur seeks immediate relief

Dabur India Ltd has taken rival firm Patanjali Ayurved to the Delhi High Court over an advertisement it has called disparaging. Dabur has alleged that the company was running a denigrating advertisement against its Chyawanprash products, according to a report by Bar & Bench,

Initially, the court asked the company to refer the case to mediation but later it decided to hear the matter after Dabur pressed for immediate relief.

The report stated that Justice Mini Pushkarna had listed the matter for hearing in the last week of January.

The Patanjali ad mentioned, “Jinko Ayurved aur Vedo ka gyaan nahi, Charak, Sushrut, Dhanwantari aur Chyawanrishi ke parampara mei ‘original’ Chyawanprash kaise bana payenge?" ('Those who do not have knowledge of Ayurveda and Vedas, how will they be able to make ‘original’ Chyawanprash').

Senior advocate Akhil Sibal, appearing for Dabur said that Patanjali Ayurved has been a habitual offender. He said that by calling Chyawanprash "ordinary", Patanjali made the product look inferior. He argued that that misleading ads denigrates other brands and create trust issues among consumers.

Patanjali Ayurved's advertisement was running in TV channels and also appeared in the Delhi edition of Dainik Jagran. Sibal said that these ads have been played 900 times in the last three days.

Meanwhile, Justice Jayant Mehta, who appeared for Patanjali has questioned the maintainability of the suit.

This year, the Supreme Court closed a contempt proceedings against Patanjali Ayurved and co-founders Baba Ramdev and Acharya Balkrishna over misleading advertisements case. The FMCG brand was embroiled in a legal battle with the Indian Medical Association (IMA) over misleading claims about allopathy medicines.

The IMA filed a defamation case against the company for spreading misinformation about allopathic medicines and claiming that it introduced drugs that can cure Covid-19 virus.

Patanjali had ran a poser, "Misconceptions Spread by Allopathy: Save Yourself and the Country from Misconceptions Spread through the Pharma and Medical Industry".

After 2-year of legal battle, both Balkrishna and Ramdev apologized to the apex court and pledged that they would never repeat past conduct.

First Published on Dec 24, 2024 7:00 PM

More from Storyboard18

Advertising

Misleading ad case: Kerala HC stays order against Baba Ramdev and Acharya Balkrishna

Misleading ad case: Kerala HC stays order against Baba Ramdev and Acharya Balkrishna

Advertising

Global social media ad spend projected to reach $239 billion in 2025, $273 billion by 2026: Report

Global social media ad spend projected to reach $239 billion in 2025, $273 billion by 2026: Report

Advertising

EXCLUSIVE: CCI examines emails of former IBDF President K Madhavan, key officials

EXCLUSIVE: CCI examines emails of former IBDF President K Madhavan, key officials

Advertising

CCI raids: Cloned data from GroupM, Dentsu puts Big Tech under scanner

CCI raids: Cloned data from GroupM, Dentsu puts Big Tech under scanner

How it Works

Creative control or creative caution? What’s really driving content choices on Indian OTTs

Creative control or creative caution? What’s really driving content choices on Indian OTTs

How it Works

CCI raids could accelerate shift from “media muscle” to “strategic agility”, writes indie ad agency Famous Innovations founder

CCI raids could accelerate shift from “media muscle” to “strategic agility”, writes indie ad agency Famous Innovations founder

Advertising

Hypothesis by OML wins Influencer Marketing mandate for Ather Energy

Hypothesis by OML wins Influencer Marketing mandate for Ather Energy

How it Works

SEBI’s ID mandate for intermediary ads welcomed, but industry seeks stronger AI oversight

SEBI’s ID mandate for intermediary ads welcomed, but industry seeks stronger AI oversight